The Global Leader in Preclinical Ophthalmic Research
EyeCRO is the global leader in preclinical ophthalmic research specializing in studies of pharmacology/efficacy, PK/tox, and eyedrop formulation development. Efficacy models include dry eye, allergic conjunctivitis, laser-induced choroidal neovascularization, STZ-induced diabetes, ischemia/reperfusion, inherited retinal degenerations, optic nerve crush, light-induced retinal degeneration, geographic atrophy, retinal vascular leakage, Oxygen-induced retinopathy, corneal neovascularization, glaucoma, experimental autoimmune uveitis, and LC-MS quantification of A2E. Proprietary MiDROPS™ technology is also available to formulate small lipophilic molecules for topical instillation (eyedrop). This clinically-validated technology platform can produce stable and safe formulations that deliver large amounts of drug into the eye with less drops.
Brands: EyeCRO®
MiDROPS®